Clinical Outcomes in Patients With CLL With Disease Progression on Ibrutinib
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Clinical outcomes in patients with chronic lymphocytic leukemia with disease progression on ibrutinib
Blood Cancer J 2022 Sep 01;12(9)124, PJ Hampel, KG Rabe, TG Call, W Ding, JF Leis, AA Chanan-Khan, SS Kenderian, E Muchtar, Y Wang, S Ailawadhi, AB Koehler, R Parrondo, SM Schwager, T Sher, CA Hanson, M Shi, DL Van Dyke, E Braggio, SL Slager, NE Kay, SA ParikhFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.